Hot Topics in Bone Disease in 2017: Building Better Bones
If you attended the Hot Topics in Bone Disease in 2017: Building Better Bones session held Wednesday, May 3, 2017 at the AACE Annual Meeting in Austin, TX, please proceed to attempt this assessment for ABIM Maintenance of Certification (MOC) credit. To begin, select the red 'Take Course' tab. You must be logged in to access the assessment.
- AACE Members: login with the same username/password used for the AACE website.
- Non-AACE Members: login using the non-member portal if you have an existing non-member account OR create an account if you are new to the AACE Education website.
Once logged in, you will be prompted to enter the access code you received onsite (found on page 7 of the Schedule-at-a-Glance). If you need assistance, please contact email@example.com.
Maintenance of Certification
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Only those who receive a passing score will be eligible for MOC credit. Please allow two weeks for MOC points to appear within your account on the ABIM website.
Participation information will be shared with the American Board of Internal Medicine (ABIM) through the Accreditation Council for Continuing Medical Education (ACCME) Program and Activity Reporting System (PARS).
- Understand the controversy surrounding calcium supplementation and be able to make common sense-based recommendations regarding calcium intake
- Appreciate the controversy surrounding definitions of vitamin D insufficiency and understand its potential impact on bone and muscle
- Recognize the importance of protein intake for older adults to minimize sarcopenia
- Become familiar with the relationship of diabetes to fracture risk
- Understand how to assess fracture risk in patients with diabetes
- Describe mechanisms of increased fracture risk
- Define the actions of anti-remodeling and anabolic agents
- Understand the differences in mechanisms of action of the types of anabolic therapy
- Position the use of anabolic agents appropriately
- Discuss the use of antiresorptive agents in breast cancer patients at high risk for fracture, particularly those receiving aromatase inhibitor therapy
- Assess the indication for denosumab as an adjuvant agent in breast cancer
- Discuss the use of anabolic (teriparatide) therapy in orthopedic spinal fusion surgery.
- Assess the efficacy of anabolic (teriparatide) therapy on fracture healing, to include atypical femoral fractures.
Rachel Pessah-Pollack, MD; Daniel Hurley, MD; Neil Binkley, MD; Nelson B. Watts, MD; Michael R. McClung, MD
- 4.00 MOC